Identification of biomarkers for glycaemic deterioration in type 2 diabetes

被引：21

作者：

Slieker, Roderick C. ^{[1
,2
]}

Donnelly, Louise A. ^{[3
]}

Akalestou, Elina ^{[4
]}

Lopez-Noriega, Livia ^{[4
]}

Melhem, Rana ^{[5
,6
]}

Gunes, Aysim ^{[6
,7
]}

Abou Azar, Frederic ^{[5
,6
]}

Efanov, Alexander ^{[8
]}

Georgiadou, Eleni ^{[4
]}

Muniangi-Muhitu, Hermine ^{[4
]}

Sheikh, Mahsa ^{[4
]}

Giordano, Giuseppe N. ^{[9
]}

Akerlund, Mikael ^{[9
]}

Ahlqvist, Emma ^{[9
]}

Ali, Ashfaq ^{[10
]}

Banasik, Karina ^{[11
]}

Brunak, Soren ^{[11
]}

Barovic, Marko ^{[12
,13
]}

Bouland, Gerard A. ^{[2
]}

Burdet, Frederic ^{[14
]}

Canouil, Mickael ^{[15
]}

Dragan, Iulian ^{[14
]}

Elders, Petra J. M. ^{[16
]}

Fernandez, Celine ^{[9
]}

Festa, Andreas ^{[17
,18
]}

Fitipaldi, Hugo ^{[9
]}

Froguel, Phillippe ^{[15
,19
]}

Gudmundsdottir, Valborg ^{[20
,21
]}

Gudnason, Vilmundur ^{[20
,21
]}

Gerl, Mathias J. ^{[22
]}

van der Heijden, Amber A. ^{[16
]}

Jennings, Lori L. ^{[23
]}

Hansen, Michael K. ^{[24
]}

Kim, Min ^{[10
,25
]}

Leclerc, Isabelle ^{[4
,5
,6
]}

Klose, Christian ^{[22
]}

Kuznetsov, Dmitry ^{[14
]}

Aly, Dina Mansour ^{[9
]}

Mehl, Florence ^{[14
]}

Marek, Diana ^{[14
]}

Melander, Olle ^{[9
]}

Niknejad, Anne ^{[14
]}

Ottosson, Filip ^{[9
,26
]}

Pavo, Imre ^{[17
]}

Duffin, Kevin ^{[8
]}

Syed, Samreen K. ^{[8
]}

Shaw, Janice L. ^{[8
]}

Cabrera, Over ^{[8
]}

Pullen, Timothy J. ^{[4
,27
]}

Simons, Kai ^{[22
]}

机构：

[1] Amsterdam UMC, Amsterdam Publ Hlth Inst, Dept Epidemiol & Data Sci, Amsterdam Cardiovasc Sci,Locat VUMC, Amsterdam, Netherlands

[2] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands

[3] Univ Dundee, Sch Med, Populat Hlth & Genom, Dundee, Scotland

[4] Imperial Coll London, Dept Metab Digest & Reprod, Div Diabet Endocrinol & Metab, Sect Cell Biol & Funct Genom, London, England

[5] CHUM Res Ctr, Montreal, PQ, Canada

[6] Univ Montreal, Montreal, PQ, Canada

[7] IRCM, Montreal, PQ, Canada

[8] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN USA

[9] Lund Univ, Dept Clin Sci, Malmo, Sweden

[10] Steno Diabet Ctr Copenhagen, Gentofte, Denmark

[11] Novo Nord Fdn, Ctr Prot Res, Copenhagen, Denmark

[12] Univ Hosp Carl Gustav Carus, Paul Langerhans Inst Dresden PLID, Helmholtz Ctr Munich, Dresden, Germany

[13] Med Fac, Dresden, Germany

[14] SIB Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland

[15] Univ Lille, Lille Univ Hosp, European Genom Inst Diabet EGID, Inst Pasteur Lille,CNRS,INSERM,U1283,UMR 8199, F-59000 Lille, France

[16] Amsterdam UMC Locat VUmc, Amsterdam Publ Hlth Res Inst, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands

[17] Eli Lilly Reg Operat GmbH, Vienna, Austria

[18] LK Stockerau, Med Dept 1, Niederosterreich, Austria

[19] Imperial Coll London, Dept Diabet Endocrinol & Metab, Div Syst Biol, London, England

[20] Univ Iceland, Fac Med, Reykjavik, Iceland

[21] Iceland Heart Assoc, Kopavogur, Iceland

[22] Lipotype GmbH, Dresden, Germany

[23] Novartis Inst Biomed Res, Cambridge, MA 02139 USA

[24] Janssen Res & Dev, Cardiovasc & Metab Dis Res, Spring House, PA USA

[25] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London, England

[26] Statens Serum Inst, Danish Ctr Neonatal Screening, Dept Congenital Disorders, Sect Clin Mass Spectrometry, Copenhagen, Denmark

[27] Guys Campus Kings Coll London, Dept Diabet, London, England

[28] Tech Univ Dresden, Univ Hosp, Mol Diabetol, Dresden, Germany

[29] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany

[30] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark

[31] Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway

[32] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Genom Diabet & Endocrinol Unit,Diabet Ctr, Malmo, Sweden

[33] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland

[34] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland

[35] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA USA

[36] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[37] Leiden Univ, Dept Biomed Data Sci, Sect Mol Epidemiol, Med Ctr, Leiden, Netherlands

[38] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore

来源：

NATURE COMMUNICATIONS | 2023年 / 14卷 / 01期

基金：

英国惠康基金; 瑞典研究理事会;

关键词：

2-AMINOADIPIC ACID; OBESE WOMEN; WEIGHT-LOSS; PROTEIN; RECEPTOR; EXPRESSION; HOMOCITRULLINE; ASSOCIATION; DEFICIENCY; METABOLISM;

D O I：

10.1038/s41467-023-38148-7

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing 2,973 individuals across three molecular classes, metabolites, lipids and proteins. Homocitrulline, isoleucine and 2-aminoadipic acid, eight triacylglycerol species, and lowered sphingomyelin 42:2;2 levels are predictive of faster progression towards insulin requirement. Of similar to 1,300 proteins examined in two cohorts, levels of GDF15/MIC-1, IL-18Ra, CRELD1, NogoR, FAS, and ENPP7 are associated with faster progression, whilst SMAC/DIABLO, SPOCK1 and HEMK2predict lowerprogression rates. In an external replication, proteins and lipids are associated with diabetes incidence and prevalence. NogoR/RTN4R injection improved glucose tolerance in high fat-fedmalemice but impaired it in male db/db mice. High NogoR levels led to islet cell apoptosis, and IL-18R antagonised inflammatory IL-18 signalling towards nuclear factor kappa-B in vitro. This comprehensive, multi-disciplinary approach thus identifies biomarkers with potential prognostic utility, provides evidence for possible disease mechanisms, and identifies potential therapeutic avenues to slow diabetes progression.

引用

页数：18

共 50 条

[1] Identification of biomarkers for glycaemic deterioration in type 2 diabetes
Roderick C. Slieker
Louise A. Donnelly
Elina Akalestou
Livia Lopez-Noriega
Rana Melhem
Ayşim Güneş
Frederic Abou Azar
Alexander Efanov
Eleni Georgiadou
Hermine Muniangi-Muhitu
Mahsa Sheikh
Giuseppe N. Giordano
Mikael Åkerlund
Emma Ahlqvist
Ashfaq Ali
Karina Banasik
Søren Brunak
Marko Barovic
Gerard A. Bouland
Frédéric Burdet
Mickaël Canouil
Iulian Dragan
Petra J. M. Elders
Celine Fernandez
Andreas Festa
Hugo Fitipaldi
Phillippe Froguel
Valborg Gudmundsdottir
Vilmundur Gudnason
Mathias J. Gerl
Amber A. van der Heijden
Lori L. Jennings
Michael K. Hansen
Min Kim
Isabelle Leclerc
Christian Klose
Dmitry Kuznetsov
Dina Mansour Aly
Florence Mehl
Diana Marek
Olle Melander
Anne Niknejad
Filip Ottosson
Imre Pavo
Kevin Duffin
Samreen K. Syed
Janice L. Shaw
Over Cabrera
Timothy J. Pullen
Kai Simons
Nature Communications, 14 (1)
[2] Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
Slieker, R. C.
Donnelly, L. A.
Lopez-Noriega, L.
Giordano, G. N.
Akerlund, M.
Pavo, I.
Lyssenko, V.
Quigley, C. Legido
Groop, L.
Ibberson, M.
Beulens, J. W. J.
' t Hart, L. M.
Pearson, E. R.
Rutter, G. A.
DIABETOLOGIA, 2021, 64 (SUPPL 1) : 108 - 108
[3] Clinical Phenotype and Rate of Glycaemic Deterioration Following Diagnosis of Type 2 Diabetes
Pearson, Ewan R.
Zhou, Kaixin
DIABETES, 2012, 61 : A373 - A374
[4] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
Louise A. Donnelly
Kaixin Zhou
Alex S. F. Doney
Chris Jennison
Paul W. Franks
Ewan R. Pearson
Diabetologia, 2018, 61 : 607 - 615
[5] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
Donnelly, Louise A.
Zhou, Kaixin
Doney, Alex S. F.
Jennison, Chris
Franks, Paul W.
Pearson, Ewan R.
DIABETOLOGIA, 2018, 61 (03) : 607 - 615
[6] Identification of relevant biomarkers for type 2 diabetes
Abbasi, Ali
Stolk, Ronald P.
Bakker, Stephan J. L.
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (02): : 106 - 107
[7] Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium
Robert W. Koivula
Ian M. Forgie
Azra Kurbasic
Ana Viñuela
Alison Heggie
Giuseppe N. Giordano
Tue H. Hansen
Michelle Hudson
Anitra D. M. Koopman
Femke Rutters
Maritta Siloaho
Kristine H. Allin
Søren Brage
Caroline A. Brorsson
Adem Y. Dawed
Federico De Masi
Christopher J. Groves
Tarja Kokkola
Anubha Mahajan
Mandy H. Perry
Simone P. Rauh
Martin Ridderstråle
Harriet J. A. Teare
E. Louise Thomas
Andrea Tura
Henrik Vestergaard
Tom White
Jerzy Adamski
Jimmy D. Bell
Joline W. Beulens
Søren Brunak
Emmanouil T. Dermitzakis
Philippe Froguel
Gary Frost
Ramneek Gupta
Torben Hansen
Andrew Hattersley
Bernd Jablonka
Jane Kaye
Markku Laakso
Timothy J. McDonald
Oluf Pedersen
Jochen M. Schwenk
Imre Pavo
Andrea Mari
Mark I. McCarthy
Hartmut Ruetten
Mark Walker
Ewan Pearson
Paul W. Franks
Diabetologia, 2019, 62 : 1601 - 1615
[8] Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium
Robert W. Koivula
Alison Heggie
Anna Barnett
Henna Cederberg
Tue H. Hansen
Anitra D. Koopman
Martin Ridderstråle
Femke Rutters
Henrik Vestergaard
Ramneek Gupta
Sanna Herrgård
Martijn W. Heymans
Mandy H. Perry
Simone Rauh
Maritta Siloaho
Harriet J. A. Teare
Barbara Thorand
Jimmy Bell
Søren Brunak
Gary Frost
Bernd Jablonka
Andrea Mari
Tim J. McDonald
Jacqueline M. Dekker
Torben Hansen
Andrew Hattersley
Markku Laakso
Oluf Pedersen
Veikko Koivisto
Hartmut Ruetten
Mark Walker
Ewan Pearson
Paul W. Franks
Diabetologia, 2014, 57 : 1132 - 1142
[9] Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium
Koivula, Robert W.
Forgie, Ian M.
Kurbasic, Azra
Vinuela, Ana
Heggie, Alison
Giordano, Giuseppe N.
Hansen, Tue H.
Hudson, Michelle
Koopman, Anitra D. M.
Rutters, Femke
Siloaho, Maritta
Allin, Kristine H.
Brage, Soren
Brorsson, Caroline A.
Dawed, Adem Y.
De Masi, Federico
Groves, Christopher J.
Kokkola, Tarja
Mahajan, Anubha
Perry, Mandy H.
Rauh, Simone P.
Ridderstrale, Martin
Teare, Harriet J. A.
Thomas, E. Louise
Tura, Andrea
Vestergaard, Henrik
White, Tom
Adamski, Jerzy
Bell, Jimmy D.
Beulens, Joline W.
Brunak, Soren
Dermitzakis, Emmanouil T.
Froguel, Philippe
Frost, Gary
Gupta, Ramneek
Hansen, Torben
Hattersley, Andrew
Jablonka, Bernd
Kaye, Jane
Laakso, Markku
McDonald, Timothy J.
Pedersen, Oluf
Schwenk, Jochen M.
Pavo, Imre
Mari, Andrea
McCarthy, Mark I.
Ruetten, Hartmut
Walker, Mark
Pearson, Ewan
Franks, Paul W.
DIABETOLOGIA, 2019, 62 (09) : 1601 - 1615
[10] Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium
Koivula, Robert W.
Heggie, Alison
Barnett, Anna
Cederberg, Henna
Hansen, Tue H.
Koopman, Anitra D.
Ridderstrale, Martin
Rutters, Femke
Vestergaard, Henrik
Gupta, Ramneek
Herrgard, Sanna
Heymans, Martijn W.
Perry, Mandy H.
Rauh, Simone
Siloaho, Maritta
Teare, Harriet J. A.
Thorand, Barbara
Bell, Jimmy
Brunak, Soren
Frost, Gary
Jablonka, Bernd
Mari, Andrea
McDonald, Tim J.
Dekker, Jacqueline M.
Hansen, Torben
Hattersley, Andrew
Laakso, Markku
Pedersen, Oluf
Koivisto, Veikko
Ruetten, Hartmut
Walker, Mark
Pearson, Ewan
Franks, Paul W.
DIABETOLOGIA, 2014, 57 (06) : 1132 - 1142

← 1 2 3 4 5 →